0001193125-11-135610.txt : 20110627 0001193125-11-135610.hdr.sgml : 20110627 20110511132011 ACCESSION NUMBER: 0001193125-11-135610 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Marina Biotech, Inc. CENTRAL INDEX KEY: 0000737207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112658569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 3830 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4259083600 MAIL ADDRESS: STREET 1: 3830 MONTE VILLA PARKWAY CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: MDRNA, Inc. DATE OF NAME CHANGE: 20080610 FORMER COMPANY: FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC DATE OF NAME CHANGE: 19920703 CORRESP 1 filename1.htm Correspondence

Roth Capital Partners, LLC

24 Corporate Plaza

Newport Beach, CA 92660

May 11, 2011

Securities and Exchange Commission

100 F Street, N.W.

Washington, D.C. 20549

 

  Re: Marina Biotech, Inc. (the “Company”)
       Registration Statement on Form S-1 (File No. 333-173108)

Ladies and Gentlemen:

In connection with the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), the undersigned hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 2:00 p.m. (NYT) on Wednesday, May 11, 2011, or as soon thereafter as practicable.

In making this request the undersigned acknowledges that it is aware of its obligations under the Act as they relate to the public offering of securities pursuant to the registration statement.

 

Very truly yours,

ROTH CAPITAL PARTNERS, LLC,

By:  

/s/ Aaron Gurewitz

Name: Aaron Gurewitz
Title: Head of Equity Capital Markets